Clinical Trial Update: COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing arNi and Ace for improving erectile dysfunction in men with reduced ejection fraction heart failure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Heart Failure
• Systolic Heart Failure

Drugs mentioned

• ARNI
• Ace (not specified)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure, Heart Failure, Systolic | Phase 3 | Status: COMPLETED | Results posted: 2024-01-08